Research Scientist (PI: Dr. Benita S. Katzenellenbogen)

Additional Campus Affiliations

Research Specialist, Molecular and Integrative Physiology

Recent Publications

Hou, Y., Nwachukwu, J. C., Carlson, K., Kim, S. H., Angle, S., Jacobsen, E. N., Woods, T., Mateus, S. L., Fanning, S. W., Ziegler, Y., Katzenellenbogen, B. S., Nettles, K. W., & Katzenellenbogen, J. A. (2025). Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α. ACS Pharmacology and Translational Science, 8(8), 2526-2535. Advance online publication. https://doi.org/10.1021/acsptsci.5c00117

Kumar, S., Ziegler, Y., Plotner, B. N., Flatt, K. M., Kim, S. H., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2024). Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death. Breast Cancer Research and Treatment, 208(2), 307-320. https://doi.org/10.1007/s10549-024-07420-9

Min, C. K., Nwachukwu, J. C., Hou, Y., Russo, R. J., Papa, A., Min, J., Peng, R., Kim, S. H., Ziegler, Y., Rangarajan, E. S., Izard, T., Katzenellenbogen, B. S., Katzenellenbogen, J. A., & Nettles, K. W. (2024). Asymmetric allostery in estrogen receptor-α homodimers drives responses to the ensemble of estrogens in the hormonal milieu. Proceedings of the National Academy of Sciences of the United States of America, 121(24), Article e2321344121. https://doi.org/10.1073/pnas.2321344121

Guillen, V. S., Ziegler, Y., Gopinath, C., Kumar, S., Dey, P., Plotner, B. N., Dawson, N. Z., Kim, S. H., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2023). Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs. Breast Cancer Research and Treatment, 198(3), 607-621. https://doi.org/10.1007/s10549-023-06878-3

Dey, P., Wang, A., Ziegler, Y., Kumar, S., Yan, S., Kim, S. H., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2022). Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer. Endocrinology, 163(12), Article bqac172. https://doi.org/10.1210/endocr/bqac172

View all publications on Illinois Experts